Phase 1 Study of ELX-02 in Healthy Adults
Clinical trial NCT03292302 · COMPLETED
Trial details
- NCT number
- NCT03292302
- Sponsor
- Eloxx Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2017-12-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.